Kamaşsk et al. found that HMGB-1 and TLR4 levels in the severe epilepsy group were significantly higher than those in the control group or the mild epilepsy group, and the mild epilepsy group was significantly higher than those in the control group in the serum of children aged 4–17. Here, TLR4 is linked to epilepsy.